Augmedix, Inc. reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported sales was USD 12.68 million compared to USD 8.75 million a year ago. Net loss was USD 4.49 million compared to USD 5.6 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9166 USD | +0.94% |
|
-8.34% | -84.33% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-84.33% | 44.88M | |
+19.76% | 73.23B | |
+10.89% | 18.02B | |
+18.76% | 14.53B | |
+16.05% | 13.13B | |
+14.46% | 10.18B | |
-15.15% | 7.28B | |
-6.51% | 5.84B | |
+7.29% | 5.38B | |
+4.60% | 5.33B |
- Stock Market
- Equities
- AUGX Stock
- News Augmedix, Inc.
- Augmedix, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023